Healthcare stocks have long been considered safe investments, providing consistent earnings and dividends despite economic changes.
However, this industry is heavily regulated, which makes it challenging for drugmakers to gain approval of new medicines, new healthcare technology, and medical devices from regulatory authorities.
Gilead Sciences Inc
Gilead Sciences Inc has an impressive track record for producing life-altering medicines, including HIV/AIDS treatments, hepatitis C therapies, and cancer remedies.
Biktarvy, Genvoya, Descovy, Odefsey, Truvada and Complera/Eviplera treatments for HIV/AIDS; Veklury injection for intravenous use to treat coronavirus disease 2019; Epclusa, Harvoni Vosevi Viread Letairis AmBisome for viral hepatitis.
Yescarta, Tecartus and Trodelvy products from the Company are designed for use in cancer therapy. Additionally, products designed specifically to treat respiratory ailments, such as Flolan (drug for pulmonary arterial hypertension) and darusentan (endothelin receptor antagonist), are developed and sold through our network.
Humana Inc
Humana Inc is a premier US health insurer offering Medicare Advantage plans, accident and dental benefits, prescription drug coverage and wellness programs.
In addition, this company provides managed care services through HMO and PPO plans, selling them both individually and group via Medicare as well as directly to employers.
Humana transformed itself in the 1990s into a consumer-focused health insurance provider by divesting itself of hospital operations, before selling them off to Columbia/HCA.
UnitedHealth Group
UnitedHealth Group is one of the world’s premier healthcare organizations, operating across three key segments – insurance, health information technology (IT), and services for healthcare provision.
Mission of Cigna Healthplan Solutions Inc: Help people live healthier lives while making the healthcare system better for all. Embark is guided by four core values – integrity, compassion, relationships and innovation/performance – when performing its services.
UnitedHealthcare operates through two subsidiaries, UnitedHealthcare and Optum. Together they offer health coverage to more than 115 million people around the globe.
Medical Marijuana Inc
Medical Marijuana Inc (OTC Pink: MJNA), is a cannabis company comprised of three distinct business units focused on non-psychoactive cannabinoids. These units include its global portfolio of cannabinoid-based nutraceuticals including Kannaway(r) and HempMeds(r); its pioneering role in procuring only top quality legal non-psychoactive cannabis products from industrial hemp; as well as clinical research and botanical drug development led by pharmaceutical investment companies including AXIM Biotechnologies Inc.
Medical Marijuana Inc offers an impressive variety of high-quality CBD products at their online store. In addition to CBD Oil, Medical Marijuana Inc provides Tinctures, Capsules, Vaporizers, Hemp Clothing and Accessories.
BIMI International Medical Inc
BIMI International Medical Inc is a China-based healthcare products and services company. It operates through four key divisions: Retail pharmacy; Medical device wholesale; Drugs wholesale; and Medical services. Within these categories lies its Wholesale Pharmaceutical segment which provides prescription and over the counter medicines as well as traditional Chinese medicine (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers.
A+ Investor evaluates BIMI on five key investing criteria: value, growth, momentum earnings revisions and quality. Stocks receive better grades for having higher quality subcomponent scores while those with lower scores receive poorer grades based on A+ Investor’s A-F grade system for each factor. With A+ Investor investors can quickly and intuitively determine whether an individual stock should be purchased, sold or held based on each factor’s A-F grade rating.
Stem Cell Authority Ltd
Stem Cell Authority Ltd is an emerging health care company with award-winning technology for birthing professionals to use the latest stem cell treatments. Furthermore, Stem Cell Authority boasts a strong financial position and growth targets which it is on target to meet. Operating out of Fairlawn, Ohio as of 2018, their flagship product is StemCellCase; an advanced cryogenic preservation solution specifically for umbilical cord blood hematopoietic stem cells.